Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Appl Environ Microbiol ; 67(7): 3174-9, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11425738

ABSTRACT

Oxidized halogen antimicrobials, such as hypochlorous and hypobromous acids, have been used extensively for microbial control in industrial systems. Recent discoveries have shown that acylated homoserine lactone cell-to-cell signaling molecules are important for biofilm formation in Pseudomonas aeruginosa, suggesting that biofouling can be controlled by interfering with bacterial cell-to-cell communication. This study was conducted to investigate the potential for oxidized halogens to react with acylated homoserine lactone-based signaling molecules. Acylated homoserine lactones containing a 3-oxo group were found to rapidly react with oxidized halogens, while acylated homoserine lactones lacking the 3-oxo functionality did not react. The Chromobacterium violaceum CV026 bioassay was used to determine the effects of such reactions on acylated homoserine lactone activity. The results demonstrated that 3-oxo acyl homoserine lactone activity was rapidly lost upon exposure to oxidized halogens; however, acylated homoserine lactones lacking the 3-oxo group retained activity. Experiments with the marine alga Laminaria digitata demonstrated that natural haloperoxidase systems are capable of mediating the deactivation of acylated homoserine lactones. This may illustrate a natural defense mechanism to prevent biofouling on the surface of this marine alga. The Chromobacterium violaceum activity assay illustrates that reactions between 3-oxo acylated homoserine lactone molecules and oxidized halogens do occur despite the presence of biofilm components at much greater concentrations. This work suggests that oxidized halogens may control biofilm not only via a cidal mechanism, but also by possibly interfering with 3-oxo acylated homoserine lactone-based cell signaling.


Subject(s)
4-Butyrolactone/analogs & derivatives , 4-Butyrolactone/metabolism , Bromates/metabolism , Hypochlorous Acid/metabolism , Signal Transduction/drug effects , Acylation , Biofilms/growth & development , Bromates/pharmacology , Chromobacterium/drug effects , Chromobacterium/metabolism , Gene Expression Regulation, Bacterial , Hypochlorous Acid/pharmacology , Laminaria/drug effects , Laminaria/enzymology , Peroxidases/metabolism , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/growth & development
2.
EMBO J ; 19(13): 3192-203, 2000 Jul 03.
Article in English | MEDLINE | ID: mdl-10880433

ABSTRACT

Stem cell factor (SCF) is an early-acting hematopoietic cytokine that elicits multiple biological effects. SCF is dimeric and occurs in soluble and membrane-bound forms. It transduces signals by ligand- mediated dimerization of its receptor, Kit, which is a receptor tyrosine kinase related to the receptors for platelet-derived growth factor (PDGF), macrophage colony-stimulating factor, Flt-3 ligand and vascular endothelial growth factor (VEGF). All of these have extracellular ligand-binding portions composed of immunoglobulin-like repeats. We have determined the crystal structure of selenomethionyl soluble human SCF at 2.2 A resolution by multiwavelength anomalous diffraction phasing. SCF has the characteristic helical cytokine topology, but the structure is unique apart from core portions. The SCF dimer has a symmetric 'head-to-head' association. Using various prior observations, we have located potential Kit-binding sites on the SCF dimer. A superimposition of this dimer onto VEGF in its complex with the receptor Flt-1 places the binding sites on SCF in positions of topographical and electrostatic complementarity with the Kit counterparts of Flt-1, and a similar model can be made for the complex of PDGF with its receptor.


Subject(s)
Proto-Oncogene Proteins c-kit/metabolism , Stem Cell Factor/chemistry , Stem Cell Factor/metabolism , Amino Acid Sequence , Cytokines/chemistry , Cytokines/metabolism , Dimerization , Humans , Models, Molecular , Molecular Sequence Data , Protein Binding , Protein Conformation , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Sequence Homology, Amino Acid
3.
Ann N Y Acad Sci ; 782: 297-310, 1996 May 15.
Article in English | MEDLINE | ID: mdl-8659906

ABSTRACT

We have modified the tryptophanase promoter (PtnaA) for use as a temperature-independent promoter for the production of recombinant proteins. Although any protein will have a temperature range in which its expression is optimal, we find the tryptophanase promoter functions at all physiologically relevant temperatures (20 degrees C to 42 degrees C). Induction at temperatures below 37 degrees C avoids eliciting the heat-shock response and may favor the production of protein in the soluble state. A short segment of the E. coli tnaA promoter containing the catabolite gene activator protein (CAP) binding site but no tryptophan-responsive elements was used to direct synthesis of various proteins. Conditions for high cell density fermentation and induction control were developed. Expression was induced by depletion of glucose and was maximal when an alternative nonrepressing carbon source was supplied. Expression of certain proteins was tightly controlled; however, pre-induction expression was observed with other reporter genes. The tnaC leader portion of the tnaA promoter was found to reduce pre-induction expression in the presence of glucose, although maximal expression was observed only in the absence of this region. The effect of temperature on expression of several recombinant proteins was investigated. Although some proteins were produced only in inclusion bodies as insoluble material, the production of one protein in soluble form was clearly temperature dependent.


Subject(s)
Cloning, Molecular/methods , Escherichia coli , Gene Expression , Promoter Regions, Genetic , Recombinant Proteins/biosynthesis , Tryptophanase/genetics , Base Sequence , Blotting, Western , Cyclic AMP Receptor Protein/biosynthesis , Cyclic AMP Receptor Protein/genetics , Escherichia coli/genetics , Fermentation , Glucose/metabolism , Molecular Sequence Data , Recombinant Proteins/isolation & purification , Restriction Mapping , Sequence Deletion , Temperature
4.
Biochim Biophys Acta ; 1260(1): 27-34, 1995 Jan 02.
Article in English | MEDLINE | ID: mdl-7999791

ABSTRACT

LIF is a multi-functional cytokine that elicits effects on a broad range of cell types. In this report, we present the high level expression of human LIF (hLIF) from a chemically synthesized gene template in Escherichia coli where it comprises up to 25% of the cellular protein. The recombinant hLIF, after purification and folding, was examined using CD, FTIR spectroscopy and light scattering. CD and FTIR spectra showed that the hLIF is an alpha-helical protein and has a distinct tertiary structure. The IFTR spectrum resembles that of other four helical bundle proteins including G-CSF and IL-6. Light scattering analysis indicated that it is a monomeric protein, distinguishing it from M-CSF and interferon gamma, which also belong to the class of four helical bundle proteins but are dimeric. Recombinant hLIF was assayed for its activity on the murine leukemic cell line, M-1 as well as on human leukemic cell line, ML-1. It inhibited the growth of M-1 cells and differentiated them towards macrophages. However, it did not have any differentiation inducing effect on human leukemic cell lines alone or in combination with other cytokines.


Subject(s)
Escherichia coli/genetics , Genes, Synthetic , Growth Inhibitors/genetics , Interleukin-6 , Lymphokines/genetics , Amino Acid Sequence , Animals , Base Sequence , Cell Differentiation/genetics , Cell Division/genetics , Circular Dichroism , Cloning, Molecular , DNA, Recombinant , Growth Inhibitors/chemistry , Humans , Leukemia Inhibitory Factor , Light , Lymphokines/chemistry , Mice , Molecular Sequence Data , Scattering, Radiation , Sequence Homology, Nucleic Acid , Spectroscopy, Fourier Transform Infrared , Tumor Cells, Cultured
5.
Leuk Res ; 17(4): 299-304, 1993 Apr.
Article in English | MEDLINE | ID: mdl-7683736

ABSTRACT

We have investigated the effect of a number of cytokines on the human acute myelomonocytic leukemic cell line, ML-1. The differentiation inducing effects of interleukins (IL-1 beta, IL-3 and IL-6), colony stimulating factors (GCSF and GMCSF), TNF, LIF and IFNg, were studied either individually or in combination. Criteria for monocytic differentiation were as follows: an increase in the percentage of cells reducing nitroblue tetrazolium (NBT) salt, an increase in the alkaline phosphatase activity as well as the appearance of macrophagic phenotype. Among all the cytokines tested, only TNF was found to induce differentiation and to inhibit growth of ML-1 cells. IL-3, IL-6, interferon gamma, GCSF and to a smaller extent IL-1 beta and GMCSF synergized the differentiation inducing activity of TNF.


Subject(s)
Cytokines/pharmacology , Leukemia, Myeloid/drug therapy , Cell Count , Cell Differentiation/drug effects , Cell Division/drug effects , Cell Survival , Culture Media , Drug Synergism , Granulocyte Colony-Stimulating Factor/pharmacology , Growth Inhibitors/pharmacology , Humans , Interferon-gamma/pharmacology , Interleukin-1/pharmacology , Interleukin-3/pharmacology , Interleukin-6/pharmacology , Leukemia Inhibitory Factor , Leukemia, Myeloid/pathology , Leukocytes/cytology , Lymphokines/pharmacology , Recombinant Proteins/pharmacology , Tumor Cells, Cultured/drug effects , Tumor Necrosis Factor-alpha/pharmacology
6.
Gene ; 67(1): 85-96, 1988 Jul 15.
Article in English | MEDLINE | ID: mdl-3138165

ABSTRACT

The genome of the cyanobacterium Synechococcus sp. PCC7942 contains two genes encoding the D2 polypeptide of photosystem II (PSII), which are designated here as psbDI and psbDII. The psbDI gene, like the psbD gene of plant chloroplasts, is cotranscribed with and overlaps the open reading frame of the psbC gene, encoding the PSII protein CP43. The psbDII gene is not linked to psbC, and appears to be transcribed as a monocistronic message. The two psbD genes encode identical polypeptides of 352 amino acids, which are 86% conserved with the D2 polypeptide of spinach. In plants, the translational start codon of the psbC gene has been reported to be an ATG codon 50 bp upstream from the end of the psbD gene. This triplet is not present in the psbDI sequence of Synechococcus sp., but is replaced by ACG, a codon which is very unlikely to initiate translation. Translation of the psbC gene may begin at a GTG codon which overlap the psbDI open reading frame by 14 bp and is preceded by a block of homology to the 3' end of the 16S ribosomal RNA, a potential ribosome-binding site. There are only two bp differences between the sequences of the two psbD genes; one of these results in substitution in psbDII of GCG for the presumed GTG start codon in psbDI.


Subject(s)
Chlorophyll/genetics , Cyanobacteria/genetics , Genes , Plant Proteins/genetics , Transcription, Genetic , Amino Acid Sequence , Base Sequence , Chloroplasts/metabolism , Cyanobacteria/metabolism , Light-Harvesting Protein Complexes , Molecular Sequence Data , Photosynthetic Reaction Center Complex Proteins , Photosystem II Protein Complex
7.
Mol Gen Genet ; 193(2): 376-8, 1984.
Article in English | MEDLINE | ID: mdl-6319974

ABSTRACT

A specialized glpK transducing phage, lambda glpK100, has been isolated and characterized with respect to DNA structure. The glpK component of the glpKF operon has been localized within a 2.0 kilobase pair (kbp) region of the approximately 8.24 kbp bacterial DNA insert, and the positions of BamHI, EcoRI and HindIII restriction sites within this DNA have been identified.


Subject(s)
Bacteriophage lambda/genetics , Escherichia coli/genetics , Glycerol Kinase/genetics , Phosphotransferases/genetics , Transduction, Genetic , Bacteriophage lambda/enzymology , DNA Restriction Enzymes , DNA, Viral/genetics , Escherichia coli/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL
...